CVAC logo

CureVac NV (CVAC) EBIT

annual EBIT:

$206.60M+$488.04M(+173.41%)
December 31, 2024

Summary

  • As of today (June 22, 2025), CVAC annual earnings before interest & taxes is $206.60 million, with the most recent change of +$488.04 million (+173.41%) on December 31, 2024.
  • During the last 3 years, CVAC annual EBIT has risen by +$682.43 million (+143.42%).
  • CVAC annual EBIT is now at all-time high.

Performance

CVAC EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

quarterly EBIT:

-$54.00M-$12.22M(-29.25%)
March 1, 2025

Summary

  • As of today (June 22, 2025), CVAC quarterly earnings before interest & taxes is -$54.00 million, with the most recent change of -$12.22 million (-29.25%) on March 1, 2025.
  • Over the past year, CVAC quarterly EBIT has increased by +$21.54 million (+28.51%).
  • CVAC quarterly EBIT is now -113.25% below its all-time high of $407.71 million, reached on September 30, 2024.

Performance

CVAC quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

TTM EBIT:

$235.38M+$21.54M(+10.07%)
March 1, 2025

Summary

  • As of today (June 22, 2025), CVAC TTM earnings before interest & taxes is $235.38 million, with the most recent change of +$21.54 million (+10.07%) on March 1, 2025.
  • Over the past year, CVAC TTM EBIT has increased by +$528.68 million (+180.26%).
  • CVAC TTM EBIT is now at all-time high.

Performance

CVAC TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CVAC EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+173.4%+28.5%+180.3%
3 y3 years+143.4%-263.3%+164.6%
5 y5 years+287.0%-120.7%+375.1%

CVAC EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+143.4%-113.3%+59.2%at high+164.6%
5 y5-yearat high+143.4%-113.3%+69.6%at high+144.0%
alltimeall timeat high+143.4%-113.3%+69.6%at high+144.0%

CVAC EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$54.00M(+29.2%)
$235.38M(+10.1%)
Dec 2024
$206.60M(-173.4%)
-$41.78M(-110.2%)
$213.85M(+32.2%)
Sep 2024
-
$407.71M(-632.7%)
$161.76M(-154.2%)
Jun 2024
-
-$76.54M(+1.3%)
-$298.30M(+1.7%)
Mar 2024
-
-$75.54M(-19.5%)
-$293.29M(+5.3%)
Dec 2023
-$281.44M(+8.1%)
-$93.87M(+79.3%)
-$278.40M(-12.2%)
Sep 2023
-
-$52.35M(-26.8%)
-$316.98M(+1.6%)
Jun 2023
-
-$71.54M(+18.0%)
-$312.08M(+3.6%)
Mar 2023
-
-$60.65M(-54.2%)
-$301.23M(+17.9%)
Dec 2022
-$260.33M
-$132.45M(+179.1%)
-$255.45M(+99.8%)
Sep 2022
-
-$47.45M(-21.8%)
-$127.85M(-48.3%)
Jun 2022
-
-$60.69M(+308.3%)
-$247.31M(-32.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$14.86M(+206.8%)
-$364.36M(-24.2%)
Dec 2021
-$475.83M(+286.7%)
-$4.84M(-97.1%)
-$480.70M(-10.2%)
Sep 2021
-
-$166.91M(-6.1%)
-$535.08M(+31.6%)
Jun 2021
-
-$177.74M(+35.5%)
-$406.63M(+75.1%)
Mar 2021
-
-$131.20M(+121.5%)
-$232.20M(+85.1%)
Dec 2020
-$123.05M(+11.4%)
-$59.23M(+54.0%)
-$125.47M(+16.6%)
Sep 2020
-
-$38.46M(+1059.3%)
-$107.63M(+21.1%)
Jun 2020
-
-$3.32M(-86.4%)
-$88.88M(+3.9%)
Mar 2020
-
-$24.47M(-40.9%)
-$85.56M(+0.6%)
Dec 2019
-$110.46M(+32.0%)
-$41.38M(+110.0%)
-$85.03M(+94.8%)
Sep 2019
-
-$19.71M(-17.7%)
-$43.65M(+82.3%)
Mar 2019
-
-$23.94M
-$23.94M
Dec 2018
-$83.67M
-
-

FAQ

  • What is CureVac NV annual earnings before interest & taxes?
  • What is the all time high annual EBIT for CureVac NV?
  • What is CureVac NV annual EBIT year-on-year change?
  • What is CureVac NV quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for CureVac NV?
  • What is CureVac NV quarterly EBIT year-on-year change?
  • What is CureVac NV TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for CureVac NV?
  • What is CureVac NV TTM EBIT year-on-year change?

What is CureVac NV annual earnings before interest & taxes?

The current annual EBIT of CVAC is $206.60M

What is the all time high annual EBIT for CureVac NV?

CureVac NV all-time high annual earnings before interest & taxes is $206.60M

What is CureVac NV annual EBIT year-on-year change?

Over the past year, CVAC annual earnings before interest & taxes has changed by +$488.04M (+173.41%)

What is CureVac NV quarterly earnings before interest & taxes?

The current quarterly EBIT of CVAC is -$54.00M

What is the all time high quarterly EBIT for CureVac NV?

CureVac NV all-time high quarterly earnings before interest & taxes is $407.71M

What is CureVac NV quarterly EBIT year-on-year change?

Over the past year, CVAC quarterly earnings before interest & taxes has changed by +$21.54M (+28.51%)

What is CureVac NV TTM earnings before interest & taxes?

The current TTM EBIT of CVAC is $235.38M

What is the all time high TTM EBIT for CureVac NV?

CureVac NV all-time high TTM earnings before interest & taxes is $235.38M

What is CureVac NV TTM EBIT year-on-year change?

Over the past year, CVAC TTM earnings before interest & taxes has changed by +$528.68M (+180.26%)
On this page